Severe early-childhood-onset retinal dystrophy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:364055H35.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Severe early-childhood-onset retinal dystrophy (sometimes called SECORD) is a group of inherited eye conditions that cause serious vision problems starting in the first few years of life. It is closely related to a condition called Leber congenital amaurosis (LCA) but is distinguished by its onset in early childhood rather than at birth. The disease affects the retina, which is the light-sensitive layer at the back of the eye responsible for converting light into signals the brain can understand. When the retina does not work properly, children experience significant vision loss that can progress over time. Key symptoms include poor vision in dim light (night blindness), reduced central and side vision, involuntary eye movements (nystagmus), and sensitivity to bright light. Children may also have sluggish or absent pupil reactions to light. Over time, the retina can show visible signs of damage, such as thinning or pigment deposits, which an eye doctor can see during an exam. The treatment landscape has changed dramatically in recent years. For patients with mutations in the RPE65 gene specifically, an FDA-approved gene therapy called voretigene neparvovec-rzyl (Luxturna) is available. This treatment delivers a working copy of the RPE65 gene directly into the retina and can meaningfully improve vision. For patients with mutations in other genes, treatment remains largely supportive, including low-vision aids, orientation and mobility training, and ongoing monitoring. Research into additional gene therapies and other approaches is actively underway for many of the other genetic causes.

Also known as:

Key symptoms:

Severe vision loss starting in early childhoodDifficulty seeing in dim light or at night (night blindness)Involuntary back-and-forth eye movements (nystagmus)Sensitivity to bright light (photophobia)Sluggish or absent pupil response to lightLoss of side (peripheral) visionLoss of central vision over timeEye poking or pressing (a habit some children develop)Difficulty tracking objects or making eye contactFarsightedness or other refractive errorsThinning of the retina visible on eye examsPigment deposits in the retinaReduced or absent signals on electroretinography (ERG) testing

Clinical phenotype terms (33)— hover any for plain English
Retinal pigment epithelial atrophyHP:0007722Abnormal corneal endothelium morphologyHP:0011488Posterior synechiae of the anterior chamberHP:0011484Posterior subcapsular cataractHP:0007787Macular pseudocolobomaHP:0001116Rhegmatogenous retinal detachmentHP:0012230Retinal degenerationHP:0000546Undetectable electroretinogramHP:0000550Abnormal pupillary light reflexHP:0007695Delayed early-childhood social milestone developmentHP:0012434Peripheral visual field lossHP:0007994
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Severe early-childhood-onset retinal dystrophy.

View clinical trials →

No actively recruiting trials found for Severe early-childhood-onset retinal dystrophy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Severe early-childhood-onset retinal dystrophy community →

No specialists are currently listed for Severe early-childhood-onset retinal dystrophy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Severe early-childhood-onset retinal dystrophy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Severe early-childhood-onset retinal dystrophyForum →

No community posts yet. Be the first to share your experience with Severe early-childhood-onset retinal dystrophy.

Start the conversation →

Latest news about Severe early-childhood-onset retinal dystrophy

No recent news articles for Severe early-childhood-onset retinal dystrophy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific gene is causing my child's retinal dystrophy, and does it qualify for gene therapy like Luxturna?,How quickly is my child's vision expected to change over the coming years?,Are there any clinical trials my child might be eligible for?,Should my child be screened for any other health problems related to this genetic condition, such as kidney issues?,What low-vision aids and educational supports should we put in place now?,How often should my child have eye exams and ERG testing to monitor progression?,What is the chance that our other children or future children could have this condition, and should family members be tested?

Common questions about Severe early-childhood-onset retinal dystrophy

What is Severe early-childhood-onset retinal dystrophy?

Severe early-childhood-onset retinal dystrophy (sometimes called SECORD) is a group of inherited eye conditions that cause serious vision problems starting in the first few years of life. It is closely related to a condition called Leber congenital amaurosis (LCA) but is distinguished by its onset in early childhood rather than at birth. The disease affects the retina, which is the light-sensitive layer at the back of the eye responsible for converting light into signals the brain can understand. When the retina does not work properly, children experience significant vision loss that can progr

At what age does Severe early-childhood-onset retinal dystrophy typically begin?

Typical onset of Severe early-childhood-onset retinal dystrophy is childhood. Age of onset can vary across affected individuals.